Medication info
Nexome Tablet 40mg (Esomeprazole Magnesium Trihydrate)

Nexome Tablet 40mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›44.5mg / 1 tablet
Manufacturer / importer
Korea Chorus Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
For domestic use: 14 tablets/AluAlu*2 For export: 28 tablets (14 tablets/AluAlu*2)
Approval status
Active

MFDS item code 201506737 · Approved 2015.09.23 · Insurance code 647203990

Summary

Main use
Treatment of reflux disease, gastrointestinal disorders (such as ulcers and Helicobacter infection), and Zollinger-Ellison syndrome
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with a liquid such as water and must not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, take for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. · Adults may take 20 mg once daily as needed. As-needed administration is not recommended for controlling persistent symptoms in patients at high risk of developing gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for eradication of Helicobacter pylori Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug use (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. No clinical trials exceeding 4 weeks have been conducted. 4) Patients requiring continuous use of nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted individually, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into 2 doses. 6) Maintenance therapy after intravenous treatment to induce prevention of rebleeding due to gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks after intravenous treatment to induce prevention of rebleeding due to gastric or duodenal ulcers. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal failure. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, do not exceed a dose of 20 mg of this medicine. 6. Older adults No dose adjustment is necessary.
Children's dosage
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, take for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. · Adults may take 20 mg once daily as needed. As-needed administration is not recommended for controlling persistent symptoms in patients at high risk of developing gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 3. Children under 12 years There is no experience with administration of this medicine to children under 12 years of age.

Ingredients

Manufacturer
Korea Chorus Co., Ltd.

Efficacy & effects

Treatment of reflux disease, gastrointestinal disorders (such as ulcers and Helicobacter infection), and Zollinger-Ellison syndrome

  • Gastroesophageal reflux disease
  • erosive reflux esophagitis
  • esophagitis
  • duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcers
  • duodenal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used for the treatment of gastroesophageal reflux disease, particularly erosive reflux esophagitis, and for long-term maintenance therapy to prevent recurrence of esophagitis. It also helps alleviate symptoms of gastroesophageal reflux disease even when esophagitis is absent. It is used in combination with antibiotics for the eradication of Helicobacter pylori in patients with Helicobacter pylori positive duodenal ulcers and peptic ulcers, and is effective in preventing recurrence of ulcers. It also aids in the treatment and prevention of upper gastrointestinal symptoms and gastric ulcers and duodenal ulcers caused by the administration of non-steroidal anti-inflammatory drugs. It is indicated for the treatment of Zollinger-Ellison syndrome and for maintenance therapies to prevent rebleeding after intravenous administration for gastric ulcers and duodenal ulcers. Therefore, this medication is widely used for the treatment and prevention of various gastrointestinal diseases and associated symptoms.

Dosage and Administration

Adult dosage

This medicine should be swallowed with a liquid such as water and must not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, take for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. · Adults may take 20 mg once daily as needed. As-needed administration is not recommended for controlling persistent symptoms in patients at high risk of developing gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for eradication of Helicobacter pylori Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug use (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. No clinical trials exceeding 4 weeks have been conducted. 4) Patients requiring continuous use of nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted individually, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into 2 doses. 6) Maintenance therapy after intravenous treatment to induce prevention of rebleeding due to gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks after intravenous treatment to induce prevention of rebleeding due to gastric or duodenal ulcers. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal failure. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, do not exceed a dose of 20 mg of this medicine. 6. Older adults No dose adjustment is necessary.

Children's dosage

2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, take for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. · Adults may take 20 mg once daily as needed. As-needed administration is not recommended for controlling persistent symptoms in patients at high risk of developing gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 3. Children under 12 years There is no experience with administration of this medicine to children under 12 years of age.

Precautions

This medication should not be administered to certain patients. For example, individuals who have had an allergy or hypersensitivity to this drug or its components, those allergic to penicillin or macrolide antibiotics, individuals currently taking certain heart-related medications, nursing mothers, those with a history of myocardial infarction, etc., should not take this medication. Caution is warranted when taking this medication as various adverse reactions may occur. Headaches, dizziness, abdominal pain, diarrhea, skin rashes, muscle pain, and rarely serious allergic reactions or blood abnormalities have been reported. Especially with prolonged use, there may be an increased risk of hypomagnesemia or fractures, thus regular testing is necessary. This medication inhibits gastric acid secretion, which may lead to the proliferation of bacteria in the stomach, potentially slightly increasing the risk of gastrointestinal infections. Additionally, this medication has a high potential for drug interactions; therefore, if taking other medications, it is essential to consult with a doctor or pharmacist. Safety data regarding use during pregnancy is limited; thus, caution should be exercised if pregnant or planning to become pregnant. In the case of nursing, it is recommended not to use this medication as it is uncertain whether this medication is transmitted through breast milk. In case of overdose, there is no specific antidote; therefore, appropriate treatment should be provided based on symptoms, and caution is needed as this medication is not easily eliminated from the body. Finally, this medication should be stored out of reach of children, and transferring it to another container may adversely affect product quality, so caution is needed.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, dysgeusia, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, hyperhidrosis, Clostridium difficile infection, abdominal bloating, allergic reaction, back pain, chest pain, retrosternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, rigidity, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, arthritis exacerbation, arthropathy, convulsions, fibromyalgia syndrome, hernia, rheumatic polymyalgia, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorder, tremors, visual field defect, dysmenorrhea, menstrual disorders, vaginitis, asthma exacerbation, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, angioedema, otitis media, altered olfaction, taste loss, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, fracture, hypocalcemia, hypokalemia, systemic lupus erythematosus, cutaneous lupus erythematosus, fundic gland polyps, rhabdomyolysis, myalgia, asthenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from exposure to air or moisture. Additionally, it is best to keep the medication at room temperature between 1°C and 30°C, away from extreme heat or cold.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

For domestic use: 14 tablets/AluAlu*2 For export: 28 tablets (14 tablets/AluAlu*2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.